Primary cultured human umbilicalvein endothelial cells were used in this study.
2
We studied their direct antiangiogenic effects on human umbilicalvein endothelial cells.
3
Tumor conditioned medium induced proliferation of human umbilicalvein endothelial cells.
4
This was also observed in situ in the endothelial cells in the umbilicalvein.
5
The expression of CD105 decreased in sclerosant treated cultured human umbilicalvein endothelial cells.
6
Additionally, the in vitro studies were performed with use of human umbilicalvein endothelial cells.
7
Recombinant human CTGF could enhance proliferation and Transwell migration of human umbilicalvein endothelial cells.
8
In human umbilicalvein endothelial cells, this occurred at what are likely physiologic intracellular ascorbate concentrations.
9
The umbilical artery is slightly more sensitive to the effects of estradiol than the umbilicalvein.
10
SVF cells were found to work together with human umbilicalvein endothelial cells to form capillary networks.
11
Here, human umbilicalvein endothelial cells were engineered using adenovirus vectors to express either ERalpha or ERbeta.
12
Inhibition of PGHS activity by acetaminophen in human umbilicalvein endothelial cells is abrogated by t-butyl hydroperoxide.
13
Methods and results: Sera from healthy children and KD subjects were incubated with human umbilicalvein endothelial cells.
14
After separation, the anti-inflammatory effects of the two compounds were evaluated using lipopolysaccharide-induced human umbilicalvein endothelial cells.
15
Cell proliferation assay showed that HRP-3 stimulated the growth of human umbilicalvein endothelial cells (HUVECs).
16
We have shown that these peptides inhibit proliferation and migration of human umbilicalvein endothelial cells in vitro.